Bank of New York Mellon
ORGS

Bank of New York Mellon’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bank of New York Mellon’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,957
Closed -$284K – 4487
2021
Q1 		$284K Buy
4,957
+546
+12% +$35.6K ﹤0.01% 3930
2020
Q4 		$199K Sell
4,411
-230
-5% -$11.1K ﹤0.01% 3978
2020
Q3 		$234K Buy
4,641
+6
+0.1% +$325 ﹤0.01% 3794
2020
Q2 		$282K Buy
+4,635
New +$280K ﹤0.01% 3708

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bank of New York Mellon's ORGS Position: Q2 2021 in Review

Bank of New York Mellon sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 4,957 shares — an estimated $284K sold.

Bank of New York Mellon first reported a position in ORGS in Q2 2020 and held it in 4 quarters. The position peaked at $284K in Q1 2021. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

  • Bank of New York Mellon reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 4,957 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $284K.
  • Bank of New York Mellon first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Bank of New York Mellon's Orgenesis Inc. Common Stock position peaked at $284K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.